Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial.
about
Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancerMetalloid compounds as drugsDrug and gene delivery across the blood-brain barrier with focused ultrasoundValidation and Comparison of the Therapeutic Efficacy of Boron Neutron Capture Therapy Mediated By Boron-Rich Liposomes in Multiple Murine Tumor Models.Synthesis and in vitro evaluation of BBB permeability, tumor cell uptake, and cytotoxicity of a series of carboranylporphyrin conjugatesTherapeutic efficacy of boron neutron capture therapy mediated by boron-rich liposomes for oral cancer in the hamster cheek pouch modelTumor targeting, trifunctional dendritic wedge.Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [(18)F]-L-FBPA positron emission tomography in boron neutron capture therapySynthesis and properties of a series of carboranyl-BODIPYs.Boron neutron capture therapy demonstrated in mice bearing EMT6 tumors following selective delivery of boron by rationally designed liposomes.Synthesis and in Vitro Studies of a Series of Carborane-Containing Boron Dipyrromethenes (BODIPYs)Boron Neutron Capture Therapy for Malignant Brain TumorsBoron neutron capture therapy outcomes for advanced or recurrent head and neck cancer.Relationship between the uptake of 18F-borono-L-phenylalanine and L-[methyl-11C] methionine in head and neck tumors and normal organs.Boron Neutron Capture Therapy - A Literature Review.The hamster cheek pouch model for field cancerization studies.Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy.Theranostic Nanoparticles Loaded with Imaging Probes and Rubrocurcumin for Combined Cancer Therapy by Folate Receptor Targeting.Chlorin e6 fused with a cobalt-bis(dicarbollide) nanoparticle provides efficient boron delivery and photoinduced cytotoxicity in cancer cells.Microlocalization of lipophilic porphyrins: non-toxic enhancers of boron neutron-capture therapy.Toward a clinical application of ex situ boron neutron capture therapy for lung tumors at the RA-3 reactor in Argentina.Biodistribution of sodium borocaptate (BSH) for boron neutron capture therapy (BNCT) in an oral cancer model.Boron neutron capture therapy (BNCT) for liver metastasis in an experimental model: dose–response at five-week follow-up based on retrospective dose assessment in individual rats.Boron neutron capture therapy for oral precancer: proof of principle in an experimental animal model.Radiobiological response of U251MG, CHO-K1 and V79 cell lines to accelerator-based boron neutron capture therapy.Boron neutron capture therapy (BNCT) translational studies in the hamster cheek pouch model of oral cancer at the new "B2" configuration of the RA-6 nuclear reactor.First experimental proof of Proton Boron Capture Therapy (PBCT) to enhance protontherapy effectiveness.Abscopal effect of boron neutron capture therapy (BNCT): proof of principle in an experimental model of colon cancer.The synthesis of boronic-imine structured compounds and identification of their anticancer, antimicrobial and antioxidant activities.Confirmation of a realistic reactor model for BNCT dosimetry at the TRIGA Mainz.Histamine reduces boron neutron capture therapy-induced mucositis in an oral precancer model.Assessing advantages of sequential boron neutron capture therapy (BNCT) in an oral cancer model with normalized blood vessels.
P2860
Q21203116-08717624-640D-4A62-97FC-CF07426C19BEQ26822682-C3D90E14-E78E-4C5D-9127-882FFC5A73F5Q28080611-12A728F0-95EC-4BAA-A539-36D3977CC729Q33875030-C5AB122F-1AB2-4F4D-92D5-3C7C0239CD78Q34061191-5A2B1972-1FCF-41CF-8C90-7535441A0176Q34526507-59825713-A53C-48E4-9BA9-9C0D6744B046Q35013469-C784C354-F9F8-4A50-85CD-A7B72B1645E5Q36184779-7361E4A7-A558-4178-96F6-C3D456D41163Q36376470-CB501D9D-A4D1-4A67-9224-65EFC6CB1EE6Q36782191-9B2C6BF6-82CC-48A2-99F8-E09AB1A4BB17Q36971353-BA9D80EE-8FAD-4AC3-9AB5-32BAD530C8D9Q37095894-7FBEF531-88F0-4DCC-8F15-E3974676FEE0Q37450696-CA702088-E46D-4EF8-A468-78D4F1278755Q37587107-5DEBAF9C-554D-4038-8A85-C1761B68F58AQ37630245-28E41EAC-A6E6-4F5C-B9B6-D204AFCDBAAAQ38286152-61801C2E-3A41-49D7-9989-CCD99937D65EQ38512169-36B62DA2-D627-461B-9878-F092B504D234Q38715691-DC2CFFFC-2D3E-49AD-B930-9647A5EEC5F9Q39060447-6DA06244-41DF-44AD-9ECF-EA8A8F1F9424Q39181823-A449B243-24E7-4576-B203-DCCA9F027F9EQ40777186-8B556A1E-5D81-4985-8A4C-A8C9872F993AQ43948866-AADF7A7D-3B5D-499B-B28C-E0D6DBD15399Q44508926-8BE068B5-1963-49B1-A40F-7C761E877C3CQ46766026-763B241C-53A4-49B7-9B6E-FFB5F9072C1FQ47184614-BAF398B6-ACEF-4D0D-A6C2-C142B718E014Q47717488-8DEC1BA7-622E-4303-A515-8416A967782CQ48042094-2E8BDE26-A42E-4A70-81BA-ACD193A9F2C1Q48269726-DB7BE764-1535-4A08-9D85-2576F0879038Q49166508-9B9798A7-C611-4EF4-9031-10137CA25004Q51016664-C6A25778-A680-419A-8B34-62435F09C810Q51743318-47DC678A-3762-4512-A99E-B095055F5436Q51748036-18AF6B2A-EFA0-40E0-BD29-D38104AAA3C6
P2860
Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Boron neutron capture therapy ...... nalysis of a phase I/II trial.
@ast
Boron neutron capture therapy ...... nalysis of a phase I/II trial.
@en
Boron neutron capture therapy ...... nalysis of a phase I/II trial.
@nl
type
label
Boron neutron capture therapy ...... nalysis of a phase I/II trial.
@ast
Boron neutron capture therapy ...... nalysis of a phase I/II trial.
@en
Boron neutron capture therapy ...... nalysis of a phase I/II trial.
@nl
prefLabel
Boron neutron capture therapy ...... nalysis of a phase I/II trial.
@ast
Boron neutron capture therapy ...... nalysis of a phase I/II trial.
@en
Boron neutron capture therapy ...... nalysis of a phase I/II trial.
@nl
P2093
P50
P1476
Boron neutron capture therapy ...... analysis of a phase I/II trial
@en
P2093
Antti Mäkitie
Eero Salli
Hanna Koivunoro
Hannu Revitzer
Juhani Collan
Leena Kankaanranta
Marko Seppänen
Mauri Kouri
Mika Kortesniemi
Petri Kotiluoto
P304
P356
10.1016/J.IJROBP.2010.09.057
P407
P577
2011-02-06T00:00:00Z